Abstract
Assessment of platelet activation and/or function is important for primary and secondary prevention of vascular events. To test the hypothesis that determination of platelet aggregation in patients with chronic-stage cerebral infarction (CI) provides a simple measure of risk for ischemic stroke, we used a conventional hematology analyzer to detect aggregates and to assess the efficacy of antiplatelet agents in preventing spontaneous aggregate formation. Platelet aggregates were measured in citrated blood from 142 magnetic resonance imaging confirmed CI patients and 97 controls without CI (nonstroke). Aggregates were detected in 1 of 36 (2.8%) nonstroke subjects without risk factors, but in 24 of 52 (46.2%) nonstroke subjects with risk factors (odds ratio [OR], 3.32; 95% confidence interval [CI], 1.10-10.00), in 21 of 35 (60.0%) nonstroke subjects with a predictive factor (carotid artery intima-media thickness [IMT] >1.1 mm) (OR, 9.13; 95% CI, 2.70-30.48), and in 31 of 63 (49.2%) CI patients who had not received antiplatelet therapy (OR, 2.16; 95% CI, 1.12-4.17). After adjusting for other risk factors, the appearance of platelet aggregates was correlated only with IMT ≥1.1 mm. The rate of appearance of platelet aggregates was 0....Continue Reading
References
Nov 1, 1990·Stroke; a Journal of Cerebral Circulation·N HandaT Kamada
Apr 1, 1990·Stroke; a Journal of Cerebral Circulation
Aug 18, 2000·The American Journal of Cardiology·M A AustinD S Sharp
Nov 2, 2002·Nature Medicine·Zaverio M Ruggeri
Apr 1, 2003·American Journal of Hematology·Mie ShimizuYasuhiko Ando
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Aug 13, 2003·International Journal of Epidemiology·X ZhangUNKNOWN Asia Pacific Cohort Studies Collaboration
Feb 14, 2004·Cardiovascular Research·Meinrad Gawaz
Jul 28, 2004·Lancet·Hans-Christoph DienerUNKNOWN MATCH investigators
Aug 17, 2004·American Heart Journal·Deepak L BhattUNKNOWN Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance Executive Committee
Aug 25, 2004·Neurology·Hisayuki HirabayashiYukito Shinohara
Mar 12, 2005·Journal of the Neurological Sciences·Laszlo K SztrihaLaszlo Vecsei
Jul 19, 2005·Thrombosis Research·Mie ShimizuYukito Shinohara
Oct 26, 2005·Circulation·Jane E Freedman
Nov 23, 2005·Circulation·UNKNOWN Asia Pacific Cohort Studies Collaboration
Dec 20, 2005·Journal of Thrombosis and Haemostasis : JTH·F M PulcinelliF Violi
Jan 28, 2006·Stroke; a Journal of Cerebral Circulation·Daniel StaubBeat Frauchiger
Apr 26, 2006·Journal of Thrombosis and Haemostasis : JTH·M ShimizuI Kuwahira
Jul 21, 2006·Pathophysiology of Haemostasis and Thrombosis·Alan D Michelson
Aug 5, 2006·Stroke; a Journal of Cerebral Circulation·Patrik HtunMeinrad Gawaz
Jan 24, 2007·Circulation·Matthias W LorenzMatthias Sitzer
Jun 6, 2007·Thrombosis and Haemostasis·Suzanne Fateh-MoghadamMeinrad Gawaz
Jun 15, 2007·Journal of Hypertension·A P KengneM Woodward
Nov 29, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·P M GorterUNKNOWN SMART Study Group
Jan 12, 2008·The American Journal of Medicine·Jeffrey S BergerRichard C Becker
Jan 18, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·G TargherG Arcaro
Jan 19, 2008·BMJ : British Medical Journal·George KrasopoulosMichael R Buchanan
Feb 19, 2008·Thrombosis and Haemostasis·Horst NeubauerAndreas Mügge